Skip to main navigation menu Skip to main content Skip to site footer
FrancoAngeli Journals

Saggi, Studi e Ricerche

No. 51 (2018)

Anti-smoking center UOC Ser.D in Cosenza: A ten-year experience

Submitted
marzo 5, 2019
Published
2019-03-07

Abstract

The study describes the care experience of smokers recruited in the Antismoke’s Centre of the Ser.D of Cosenza (ASP Cosenza - Calabrian Region) in 10 years of activity. The Centre has prepared a therapeutic care run supplementing the positive effects of the perfect medicine (varenicline) for the smoking cessation with a psico-educational approach looked at improving and at supporting the user addressing it towards a positive and ripe motivation to stop being smoked. There is in way, besides, the formulation of a protocol of agreement between the Antismoke’s Centre and the local network of Pneumology and Cardiology centers to prevent and treat smoke-related pathologies.

References

  1. Arch J.J., Craske M.G. (2008). Acceptance and commitment therapy and cognitive behavioral therapy for anxiety disorders: Different treatments, similar mechanisms? Clinical Psychology. Science and Practice, 15: 263-279.
  2. Attwood A.S., Williams T., Adams S., McClernon F.J., Munafò M.R. (2014). Effects of varenicline and cognitive bias modification on neural response to smoking-related cues: study protocol for a randomized controlled study. Trials, Oct, 15: 391.
  3. Beck A.T. (1979). Cognitive therapy and the emotional disorders. New York: Meridian.
  4. D’Amore B. (1996). Problemi. Pedagogia e psicologia della matematica nell’attività di problem solving. Milano: FrancoAngeli.
  5. Duval R (1993). Registres de représentations sémiotique et fonctionnement cognitif de la pensée. In: Annales de Didactique et de Sciences Cognitives. Strasbourg: ULP, IREM.
  6. Gonzales D., Hajek P., Pliamm L., Nackaerts K., Tseng L.J., McRae T.D., Treadow J. (2014). Retreatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trial. Clin Pharmacol Ther, Sep, 96(3): 390-6.
  7. Hobbs S., Chiesa M. (2011). The Myth of the “Cognitive Revolution”. European Journal of Behavior Analysis, 12: 385-394.
  8. Kadden R.M. (2002). Cognitive-Behavior Therapy for substance Dependence: Coping Skills Training.
  9. La Marca A. (1999). Didattica e sviluppo della competenza metacognitiva. Voler apprendere per imparare a pensare. Palermo: Palumbo.
  10. Leahy R.L. (2008). A closer look at ACT. Behavior Therapist, 31: 148.
  11. Mc Clure E.A., Vandrey R.G., Johnson M.W., Stitzer M.L. (2013). Effects of varenicline on abstinence and smoking reward following a programmed lapse. Nicotine Tob Res., Jan, 15(1): 139-48.
  12. Mosconi G., D’Urso V. (1973). La soluzione dei problemi. Firenze: Giunti, Barbera.
  13. Rose J.E., Behm F.M. (2014). Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm. Am J Psychiatry, Nov, 171(11): 1199-205.
  14. Stein M.D., Caviness C.M., Kurth M.E., Audet D., Olson J., Anderson B.J. (2013). Varenicline for smoking cessation among methadonemaintained smokers: a randomized clinical trial. Drug Alcohol Depend., 133(2): 486-93.
  15. Sutherland M.T., Carroll A.J., Salmeron B.J., Ross T.J., Hong L.E., Stein E.A. (2013). Down-regulation of amygdala and insula functional circuits byvarenicline and nicotine in abstinent cigarette smokers. Biol Psychiatry, Oct 1, 74(7): 538-46.

Metrics

Metrics Loading ...